Profound Medical Corp Forecast, price target & analysts
Profound Medical Corp Target price 2025 - Analyst rating & recommendation
Profound Medical Corp Classifications & Recommendation:
Profound Medical Corp Price Target
| Target Price | $15.30 |
| Price | $7.15 |
| Potential |
113.99%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Profound Medical Corp 2026 .
The average Profound Medical Corp target price is $15.30.
This is
113.99%
register free of charge
$18.00
151.75%
register free of charge
$12.00
67.83%
register free of charge
|
|
| A rating was issued by 5 analysts: 5 Analysts recommend Profound Medical Corp to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Profound Medical Corp stock has an average upside potential 2026 of
113.99%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 7.20 | 11.23 |
| 7.78% | 55.90% | |
| EBITDA Margin | -381.53% | -265.18% |
| 8.98% | 30.50% | |
| Net Margin | -462.38% | -268.02% |
| 9.24% | 42.03% |
4 Analysts have issued a sales forecast Profound Medical Corp 2024 . The average Profound Medical Corp sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Profound Medical Corp EBITDA forecast 2024. The average Profound Medical Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Profound Medical Corp 2024 . The average Profound Medical Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.35 | -1.22 |
| 2.17% | 9.63% | |
| P/E | negative | |
| EV/Sales | 17.27 |
1 Analysts have issued a Profound Medical Corp forecast for earnings per share. The average Profound Medical Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Profound Medical Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Profound Medical Corp...
Current Profound Medical Corp Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RAYMOND JAMES LTD. | Locked ➜ Locked | Locked | Dec 10 2024 |
| LEEDE JONES GABLE | Locked ➜ Locked | Locked | Nov 03 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
RAYMOND JAMES LTD.: Locked ➜ Locked
|
Dec 10 2024 |
|
Locked
LEEDE JONES GABLE: Locked ➜ Locked
|
Nov 03 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
